FINAL SAY ON GADOLINIUM IN MRI CONTRAST?
Gadolinium has been a controversial subject when it comes to imaging in the last few months. Earlier in the year, the European Medicines Agency recommended pulling the agent from the market, while last month the FDA said it will continue to monitor the agent, but so far has not found it causes harm. Now, a Mayo Clinic study shows post-mortem findings of pediatric patients with gadolinium present.
So what is the final say? There’s no clear answer yet, but regardless, it is our duty as healthcare professionals to ensure patient safety. That is why the SAMM System and SAMM MD are perfect for ensuring quality and safety within your MRI facility. Let patients feel at ease knowing they are carefully monitored while allowing your facility to keep accurate records.
Thank you for visiting our blog!